Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fedovapagon (VA106483) is a selective and potent agonist of the vasopressin V2 receptor (V2R) that inhibits the growth of intersegmental vessels in zebrafish. Fedovapagon can be used to study overactive bladder, nocturia, and painful bladder syndromes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 113.00 | |
10 mg | In stock | $ 179.00 | |
25 mg | In stock | $ 392.00 | |
50 mg | In stock | $ 689.00 | |
100 mg | In stock | $ 973.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 126.00 |
Description | Fedovapagon (VA106483) is a selective and potent agonist of the vasopressin V2 receptor (V2R) that inhibits the growth of intersegmental vessels in zebrafish. Fedovapagon can be used to study overactive bladder, nocturia, and painful bladder syndromes. |
Targets&IC50 | V2R:24 nM (EC50) |
In vivo | In rats, oral administration of fedovapagon at a dose of 1 mg/kg results in an 81% inhibition rate of urine output[1]. |
Synonyms | VA483, A106483 |
Molecular Weight | 462.58 |
Formula | C27H34N4O3 |
CAS No. | 347887-36-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (108.08 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fedovapagon 347887-36-9 GPCR/G Protein Vasopressin Receptor VA483 A106483 inhibitor inhibit